Evidence map›Paper›PMID 41290690›Full record

Observational studyScientific reports2025

Sero-surveillance of SARS-CoV-2 specific antibody (IgG) among garment workers in Bangladesh.

Nafisa Mosaddek, Hrishik Iqbal, Fatima Farhana, Md Siddiqul Islam, K M Nazmul Hossain, Md Saiful Islam, K M Rakibul Hasan, Abu Syed Md Mosaddek

Erratum issuedAbstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Nafisa MosaddekBangladesh University of Professionals, Dhaka, Bangladesh.
Hrishik IqbalBrac University, Dhaka, Bangladesh. hrishik.iqbal@g.bracu.ac.bd.
Fatima FarhanaUttara Adhunik Medical College, Dhaka, Bangladesh.
Md Siddiqul IslamSoutheast University, Dhaka, Bangladesh.
K M Nazmul HossainQuest Bangladesh, Dhaka, Bangladesh.
Md Saiful IslamJahangirnagar University, Savar, Bangladesh.
K M Rakibul HasanConsultant & Child Development Therapist Paediatric Neurocare & Research (PNR), Dhaka, Bangladesh.
Abu Syed Md MosaddekUttara Adhunik Medical College, Dhaka, Bangladesh. drmosaddek1968@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the first detected COVID-19 case in Bangladesh on March 8, 2020, the virus spread rapidly across the country. Despite challenges such as limited healthcare facilities, diagnostic resources, and public awareness, the prevalence of severe symptomatic COVID-19 infections among Bangladeshi working populations, including garment workers, has remained relatively low. This study aimed to determine the sero-prevalence of SARS-CoV-2-specific IgG antibodies among Bangladeshi garment workers. A cross-sectional observational study was conducted on 402 garment workers (69.4% female; mean age = 28.9 ± 6.9 years) in Dhaka. A semi-structured questionnaire was used to collect demographic and COVID-19-related data. Blood samples were analyzed for SARS-CoV-2-specific IgG using a Chemiluminescent Immunoassay. The seroprevalence of SARS-CoV-2-specific IgG antibodies among garment workers was 80.8% (95% CI: 77.1-84.3). No significant differences were observed based on sex, age, marital status, residence, or economic status. Seropositivity was higher among those with RT-PCR-confirmed COVID-19 (96.4%) compared to those without confirmation (79.7%), though the difference was not statistically significant (p = 0.054). A significant association was found between comorbid conditions (hypertension, diabetes, asthma) and lower seropositivity (53.3% vs. 81.9%, p = 0.015). No significant differences were observed in seropositivity across age, education, marital status, residence, or economic status. High seroprevalence suggests widespread exposure among garment workers, potentially due to occupational factors or preexisting immunity from prior coronavirus infections. Future studies should assess long-term immunity and its implications.

Indexed as

Antibodies, ViralClothingCOVID-19Immunoglobulin GSARS-CoV-2AdultBangladeshCross-Sectional StudiesFemaleHumansMaleMiddle AgedSeroepidemiologic StudiesYoung AdultAntibodies, ViralImmunoglobulin GAntibodyBangladeshGarment workersSARS-CoV-2Sero-surveillance

Identifiers

PMID41290690
PMCPMC12657904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.